A Multicenter, Prospective, Open-label, Randomized Trial to Compare the Efficacy of Silodosin And Naftopidil In Patients With Benign Prostatic Enlargement (BPE) Complicated By Overactive Bladder (OAB).

Trial Profile

A Multicenter, Prospective, Open-label, Randomized Trial to Compare the Efficacy of Silodosin And Naftopidil In Patients With Benign Prostatic Enlargement (BPE) Complicated By Overactive Bladder (OAB).

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Silodosin (Primary) ; Naftopidil
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Acronyms SNIPER
  • Most Recent Events

    • 24 Oct 2016 New trial record
    • 08 Sep 2016 Results of this trial, published in the Journal of Urology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top